Deutsche Bank
DNA icon

Deutsche Bank’s Ginkgo Bioworks DNA Stock Holding History

Deutsche Bank’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$785K Sell
61,212
-3,911
-6% -$31.9K ﹤0.01% 2379
2026
Q2 		$645K Buy
65,123
+25,330
+64% +$212K ﹤0.01% 2633
2026
Q1 		$244K Buy
39,793
+4,104
+11% +$34.1K ﹤0.01% 2923
2025
Q4 		$297K Buy
35,689
+1,207
+4% +$13K ﹤0.01% 2831
2025
Q3 		$503K Buy
34,482
+3,535
+11% +$42.3K ﹤0.01% 2538
2025
Q2 		$348K Buy
30,947
+28,957
+1,455% +$224K ﹤0.01% 2644
2025
Q1 		$11.3K Sell
1,990
-2,051
-51% -$20.9K ﹤0.01% 3495
2024
Q4 		$39.7K Hold
4,041
– – ﹤0.01% 3452
2024
Q3 		$32.9K Buy
4,041
+2,217
+122% +$22.2K ﹤0.01% 3420
2024
Q2 		$24.1K Sell
1,824
-70
-4% -$2.09K ﹤0.01% 3414
2024
Q1 		$87.9K Buy
1,894
+216
+13% +$11.2K ﹤0.01% 3220
2023
Q4 		$113K Sell
1,678
-11
-0.7% -$674 ﹤0.01% 3167
2023
Q3 		$122K Buy
1,689
+1
+0.1% +$80 ﹤0.01% 3060
2023
Q2 		$126K Buy
1,688
+1,620
+2,382% +$95.9K ﹤0.01% 3163
2023
Q1 		$3.59K Sell
68
-2,968
-98% -$188K ﹤0.01% 3843
2022
Q4 		$205K Buy
+3,036
New +$279K ﹤0.01% 2967
2022
Q3 		– Sell
-663
Closed -$63K – 3993
2022
Q2 		$63K Buy
+663
New +$80.9K ﹤0.01% 3692

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return

Deutsche Bank's DNA Position: Q3 2026 in Review

Deutsche Bank reduced its Ginkgo Bioworks (DNA) stake by 6% in Q3 2026, selling an estimated $31.9K and leaving 61,212 shares worth $785K. The position accounts for ﹤0.01% of the portfolio, ranked #2379.

Deutsche Bank first reported a position in DNA in Q2 2022 and has held it in 17 quarters since. 64 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Deutsche Bank held 61,212 shares of Ginkgo Bioworks worth $785K as of Q3 2026.
  • Deutsche Bank sold 3,911 Ginkgo Bioworks shares in Q3 2026, an estimated $31.9K.
  • Ginkgo Bioworks made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2379 holding.
  • Deutsche Bank first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 17 quarters since.
  • 64 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.